📰 Frontier Biotech News
Frontier Biotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Frontier Biotech. Real-time updates on events, politics, business and more.
August 10, 2022
Atlanta (Georgia) [US], August 10 (ANI/PRNewswire): Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the Phase 1 clinical trial of its drug candidate, FB2001 - a small molecule inhibitor of coronavirus main protease (Mpro) - in healthy adult volunteers. The data, presented today at the poster session of the 11th International Conference on Emerging Inf...
June 22, 2022
Clinical trial results showed that Chinas first domestically developed drug for the treatment of HI
June 22, 2022
Chinas first domestically developed anti-HIV drug clinically safe, effective: study-
June 22, 2022
Beijing, Jun 22 (EFE).- The first drug developed in China for the treatment of HIV has proved to be safe and effective in the results of clinical trials, state-owned Xinhua agency reported Wednesday. Aikening, or albuvirtide (ABT) is a generic drug belonging to a group of anti-HIV drugs called a fusion inhibitor, which block the …
April 27, 2022
27.04.2022 MIG Capital continues to grow after excellent financial year 2021 | Biontech | Creative Balloons | Hemovent
December 22, 2021
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China GlobeNewswire December 22, 2021 Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration accelerates the global development of AFFiRiS potential first-in-class active immunotherapy with plans to...